Latest News

4 Stocks Insiders Are Selling



Nektar Therapeutics Insider Trades $315K In Company Stock

Gil Labrucherie, CFO at Nektar Therapeutics (NASDAQ:NKTR), made a large insider sell on November 18, according to a new SEC filing. What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Thursday showed that Labrucherie sold 24,149 shares of Nektar Therapeutics at prices ranging from $12.69 to $13.16. The total transaction amounted to $316,391. Following the transaction, Labrucherie still owns 256,682 shares of Nektar Therapeutics worth $3,100,718.00. Nektar Therapeut

Column: Wells Fargo found another way to abuse customers. Then I called them on it

Previous article

JetBlue dangles $1,000 attendance bonuses for flight attendants ahead of holiday rush

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News